1. Home
  2. CMCT vs BIVI Comparison

CMCT vs BIVI Comparison

Compare CMCT & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

N/A

Current Price

$5.07

Market Cap

13.7M

Sector

Real Estate

ML Signal

N/A

Logo BioVie Inc.

BIVI

BioVie Inc.

N/A

Current Price

$1.15

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMCT
BIVI
Founded
1993
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
12.4M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
CMCT
BIVI
Price
$5.07
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $5.26
AVG Volume (30 Days)
37.9K
★ 811.3K
Earning Date
11-16-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.83
EPS
N/A
★ N/A
Revenue
★ $116,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.78
$0.82
52 Week High
$1,441.00
$3.79

Technical Indicators

Market Signals
Indicator
CMCT
BIVI
Relative Strength Index (RSI) 63.87 41.73
Support Level $4.91 $1.15
Resistance Level $5.62 $1.47
Average True Range (ATR) 0.42 0.22
MACD 0.15 -0.01
Stochastic Oscillator 90.75 3.54

Price Performance

Historical Comparison
CMCT
BIVI

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is a Maryland corporation and REIT. It mainly acquires, develops, owns, and operates both multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to multifamily investments. All of its communities are located in areas that include traditional downtowns and suburban main streets, which have high barriers to entry, high population density, positive population trends, and a propensity for growth. Currently, the company consists of three types of commercial real estate properties, namely office, hotel, and multifamily.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.

Share on Social Networks: